GlassScriptPhysician profile
Lynnette A Davis
NPI 1225260920
$1,012.11
in general payments reported to CMS, 2019-2025
13 companies · $433 in 2025
The $433 reported for 2025 was more than what 94% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.60 · 2023: $227 · 2024: $340 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $267.72 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $156.99 | 2024-2025 | Gemtesa, Myfembree |
| Organon LLC | $127.78 | 2022-2025 | Nexplanon |
| Abbvie INC. | $107.35 | 2023-2025 | |
| Biogen, INC. | $105.16 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $58.99 | 2023-2025 | |
| Boston Scientific Corporation | $53.07 | 2024-2025 | Advantage System, Bulkamid |
| Pfizer INC. | $32.87 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.25 | 2024 | Fruzaqla |
| Radius Health, INC. | $21.90 | 2024 | Tymlos |
| Mayne Pharma Commercial LLC | $20.95 | 2025 | |
| Baxter Healthcare | $19.86 | 2023 | |
| Exeltis, USA INC. | $13.22 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynnette Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.